Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer-Reference-Cited by-同舟云学术

Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer

Published:2016-02-16 Issue:10 Volume:138 Page:2499-2509
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Peng Cike¹²,Wallwiener Markus³⁴,Rudolph Anja⁵,Ćuk Katarina¹²,Eilber Ursula⁵,Celik Muhabbet⁵,Modugno Caroline³⁴,Trumpp Andreas⁶⁷,Heil Jörg³,Marmé Frederik²,Madhavan Dharanija¹²,Nees Juliane³⁴,Riethdorf Sabine⁸,Schott Sarah³,Sohn Christof³,Pantel Klaus⁸,Schneeweiss Andreas³⁴,Chang-Claude Jenny⁵,Yang Rongxi¹²,Burwinkel Barbara¹²

Affiliation:

1. Molecular Epidemiology; German Cancer Research Center (DKFZ); Heidelberg Germany

2. Molecular Biology of Breast Cancer; Department of Obstetrics and Gynecology; University of Heidelberg; Heidelberg Germany

3. Department of Obstetrics and Gynecology; University of Heidelberg; Heidelberg Germany

4. National Center for Tumor Diseases, University of Heidelberg; Heidelberg Germany

5. Division of Genetic Epidemiology; German Cancer Research Center (DKFZ); Heidelberg Germany

6. Hi-STEM-Heidelberg Institute for Stem Cell Technology and Experimental Medicine GmbH; Heidelberg Germany

7. Division of Stem Cells and Cancer; German Cancer Research Center (DKFZ); Heidelberg Germany

8. Department of Tumor Biology; University Hospital Hamburg-Eppendorf; Hamburg Germany

Funder

Dietmar-Hopp Foundation, the University Hospital of Heidelberg, the Helmholtz Society, the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases, (IFP-Project I.2)

China Scholarship Council (CSC; for a 4-year PhD program; C.P.)

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.29975/fullpdf

Reference40 articles.

1. CTCs in metastatic breast cancer;Giordano;Recent Results Cancer Res,2012

2. Second consensus on medical treatment of metastatic breast cancer;Beslija;Ann Oncol,2007

3. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay;Baccelli;Nat Biotechnol,2013

4. Considerations in the development of circulating tumor cell technology for clinical use;Parkinson;J Transl Med,2012

5. The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer;Wallwiener;Breast Cancer Res Treat,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Hyaluronan Synthesis in Cancer: A Road Less Travelled;Biologics;2023-12-12

2. Nanomedicine Strategies for Targeting Tumor Stroma;Cancers;2023-08-17

3. An Innovative Electrochemical Immuno-Platform for Monitoring Chronic Conditions Using the Biosensing of Hyaluronic Acid in Human Plasma Samples;Chemosensors;2023-06-29

4. Role of Hyaluronic Acid in Selected Malignant Neoplasms in Women;Biomedicines;2023-01-21

5. Dual targeting nanoparticles based on hyaluronic and folic acids as a promising delivery system of the encapsulated 4-Methylumbelliferone (4-MU) against invasiveness of lung cancer in vivo and in vitro;International Journal of Biological Macromolecules;2022-05